STEM-engineered CAR T cells performed as well as or better against cancer cells than did FDA-approved CAR T cells and kept their cancer-fighting abilities for longer.
A new type of CAR T-cell therapy elicits a more controlled immune response to cancer in mice, effectively killing cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback